Talus Bio

Talus Bioscience is a venture-backed early-stage biotechnology startup company working on drug development for gene regulators. Talus Bio spun out of two leading institutions in September 2020 (University of Washington and Altius Institute for Biomedical Sciences) and is located in Seattle, WA. We are building a data-enabled drug development platform that will focus primarily on small-molecule drug development in oncology. Talus Bio's platform measures a drug's ability to disrupt a gene regulator within its natural, non-engineered cellular environment. Furthermore, a single experiment using the platform measures activity for about 1,000 gene regulators simultaneously, providing information on in-cell drug activity and specificity in a single experiment. To accomplish this, we combine innovative cell processing with high-sensitivity quantitative proteomics and advanced downstream analytics. As a company, Talus Bio focuses on two parallel efforts to prove that our technology can open up the world of gene regulation for drug discovery: - Developing internal programs against previously undruggable gene regulators in cancers with poor standard of care - Partnering with pharma, biotech, and academic labs to help progress their pipeline of gene regulator drugs

Research Seattle, United States ~26 employees Private ยท Seed

Work at Talus Bio in HR or recruiting? Claim this page

Employees
26
-3.7% in the 3 months to Sep 2026
Revenue / employee
$76.9K
Revenue ~$2M
Total funding
$26.8M
Last round Seed, Aug 2024
12-month attrition
13%
Tech: 20%
H1B sponsor
NA

Headcount trend

Talus Bio went from 21 employees in Oct 2024 to 26 in Sep 2026. Apr to Sep 2026: 2 people joined, 1 left.

Funding rounds

Total funding$26.8M
Funding rounds5
Investors12

Org structure

Headcount by department

Other17
Operations4
Engineering3
Finance1
Sales1

Hiring now

Talus Bio FAQ

How many employees does Talus Bio have?

Talus Bio has about 26 employees, down 3.7% over the 3 months to Sep 2026.

What is Talus Bio's revenue per employee?

Talus Bio makes about $77K in revenue per employee, based on $2M annual revenue and 26 employees.

How much funding has Talus Bio raised?

Talus Bio has raised $26.75M in total funding; its latest round was Seed in Aug 2024.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.